Genomic Vision Announces the Issuance of 2 New Tranches of C

Genomic Vision Announces the Issuance of 2 New Tranches of Convertible Notes With Warrants (OCABSA) for €2 Million, as Part of the Financing Line Concluded With Winance for a Maximum Amount of €12 Million

Regulatory News: Genomic Vision(the "Company" FR0011799907 GV) (Paris:GV), a biotechnology company that develops tools and services dedicated to the analysis and control of changes in the genome

Related Keywords

Paris , France General , France , Bagneux , Dominique Remy Renou , Strategic Communications , Euronext , Genomic Vision The Company , Regulatory News , Genomic Vision , Executive Board , Universal Registration Document , Genomic , Vision , Nnounces , Issuance , Branches , Convertible , Votes , Ith , Warrants , Ocabsa , Billion , Art , Financing , Line , Oncluded , Inance , Maximum , Amount ,